Valley National Advisers Inc Astrazeneca PLC Transaction History
Valley National Advisers Inc
- $554 Million
- Q3 2024
A detailed history of Valley National Advisers Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Valley National Advisers Inc holds 22,962 shares of AZN stock, worth $1.52 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
22,962
Previous 350
6460.57%
Holding current value
$1.52 Million
Previous $27,000
6522.22%
% of portfolio
0.32%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...